125 related articles for article (PubMed ID: 30538387)
1. Pelvic Exenteration Put into Therapeutical and Palliative Perspective: It Is Worth to Try.
Karmaniolou I; Arkadopoulos N; Vassiliou P; Nastos C; Dellaportas D; Siatelis A; Theodosopoulos T; Vezakis A; Parasyris S; Polydorou A; Smyrniotis V
Indian J Surg Oncol; 2018 Dec; 9(4):552-557. PubMed ID: 30538387
[TBL] [Abstract][Full Text] [Related]
2. Indications for primary and secondary exenterations in patients with cervical cancer.
Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
[TBL] [Abstract][Full Text] [Related]
3. Complications of radical cystectomy.
Buscarini M; Pasin E; Stein JP
Minerva Urol Nefrol; 2007 Mar; 59(1):67-87. PubMed ID: 17431372
[TBL] [Abstract][Full Text] [Related]
4. Critical evaluation of contemporary management in a new Pelvic Exenteration Unit: The first 25 consecutive cases.
Chew MH; Yeh YT; Toh EL; Sumarli SA; Chew GK; Lee LS; Tan MH; Hennedige TP; Ng SY; Lee SK; Chong TT; Abdullah HR; Goh TLH; Rasheed MZ; Tan KC; Tang CL
World J Gastrointest Oncol; 2017 May; 9(5):218-227. PubMed ID: 28567186
[TBL] [Abstract][Full Text] [Related]
5. Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan.
Maggioni A; Roviglione G; Landoni F; Zanagnolo V; Peiretti M; Colombo N; Bocciolone L; Biffi R; Minig L; Morrow CP
Gynecol Oncol; 2009 Jul; 114(1):64-8. PubMed ID: 19411097
[TBL] [Abstract][Full Text] [Related]
6. Influence of tumor size on outcomes following pelvic exenteration.
Smith B; Jones EL; Kitano M; Gleisner AL; Lyell NJ; Cheng G; McCarter MD; Abdel-Misih S; Backes FJ
Gynecol Oncol; 2017 Nov; 147(2):345-350. PubMed ID: 28822555
[TBL] [Abstract][Full Text] [Related]
7. Prediction of short-term surgical complications in women undergoing pelvic exenteration for gynecological malignancies.
Tortorella L; Casarin J; Mara KC; Weaver AL; Multinu F; Glaser GE; Cliby WA; Scambia G; Mariani A; Kumar A
Gynecol Oncol; 2019 Jan; 152(1):151-156. PubMed ID: 30414740
[TBL] [Abstract][Full Text] [Related]
8. Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution.
Jäger L; Nilsson PJ; Rådestad AF
Int J Gynecol Cancer; 2013 May; 23(4):755-62. PubMed ID: 23407096
[TBL] [Abstract][Full Text] [Related]
9. Major complications following exenteration in cases of pelvic malignancy: a 10-year experience.
Wydra D; Emerich J; Sawicki S; Ciach K; Marciniak A
World J Gastroenterol; 2006 Feb; 12(7):1115-9. PubMed ID: 16534855
[TBL] [Abstract][Full Text] [Related]
10. Salvage Surgery for Cervical Cancer Recurrences.
Rema P; Mathew AP; Suchetha S; Ahmed I
Indian J Surg Oncol; 2017 Jun; 8(2):146-149. PubMed ID: 28546709
[TBL] [Abstract][Full Text] [Related]
11. Comparison of postoperative complications and quality of life between patients undergoing continent versus non-continent urinary diversion after pelvic exenteration for gynecologic malignancies.
Angeles MA; Mallet E; Rouanet P; Cabarrou B; Méeus P; Lambaudie E; Foucher F; Narducci F; Loaec C; Gouy S; Guyon F; Marchal F; Gladieff L; Martínez-Gómez C; Migliorelli F; Martinez A; Ferron G
Int J Gynecol Cancer; 2020 Feb; 30(2):233-240. PubMed ID: 31796531
[TBL] [Abstract][Full Text] [Related]
12. Gynecologic Oncology: Pelvic Exenteration for Advanced or Recurring Cervical Cancer - A Single Center Analysis.
Glane LT; Hegele A; Wagner U; Boekhoff J
Cancer Diagn Progn; 2022; 2(3):308-315. PubMed ID: 35530642
[TBL] [Abstract][Full Text] [Related]
13. Pelvic exenteration for advanced pelvic malignancy.
Crowe PJ; Temple WJ; Lopez MJ; Ketcham AS
Semin Surg Oncol; 1999; 17(3):152-60. PubMed ID: 10504662
[TBL] [Abstract][Full Text] [Related]
14. Pelvic exenteration for recurrent cervical cancer: ten-year experience at National Cancer Center in Korea.
Yoo HJ; Lim MC; Seo SS; Kang S; Yoo CW; Kim JY; Park SY
J Gynecol Oncol; 2012 Oct; 23(4):242-50. PubMed ID: 23094127
[TBL] [Abstract][Full Text] [Related]
15. [Outcomes of perisurgery and short-time follow-up of pelvic exenteration for 17 cases with locally recurrent cervical cancer].
Deng H; Wang JL; Wang ZQ; Li XW; Hu H; Yang B; Zhang XM; Shen K; Guo P; Liang B
Zhonghua Fu Chan Ke Za Zhi; 2020 Apr; 55(4):259-265. PubMed ID: 32375433
[No Abstract] [Full Text] [Related]
16. The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer.
Jalloul RJ; Nick AM; Munsell MF; Westin SN; Ramirez PT; Frumovitz M; Soliman PT
J Gynecol Oncol; 2018 Sep; 29(5):e68. PubMed ID: 30022632
[TBL] [Abstract][Full Text] [Related]
17. Pelvic exenterations for gynecological malignancies: a study of 36 cases.
Kaur M; Joniau S; D'Hoore A; Van Calster B; Van Limbergen E; Leunen K; Penninckx F; Van Poppel H; Amant F; Vergote I
Int J Gynecol Cancer; 2012 Jun; 22(5):889-96. PubMed ID: 22617477
[TBL] [Abstract][Full Text] [Related]
18. [Urinary complications of pelvic exenterations for rectal cancer with urinary invasion].
Gas J; Beauval JB; Chalret du Rieu M; Bou Nasr E; Philis A; Kirzin S; Thoulouzan M; Soulié M; Ghouti L
Prog Urol; 2015 May; 25(6):348-54. PubMed ID: 25804429
[TBL] [Abstract][Full Text] [Related]
19. Urological complications after cystectomy as part of pelvic exenteration are higher than that after cystectomy for primary bladder malignancy.
Brown KG; Solomon MJ; Latif ER; Koh CE; Vasilaras A; Eisinger D; Sved P
J Surg Oncol; 2017 Mar; 115(3):307-311. PubMed ID: 27859276
[TBL] [Abstract][Full Text] [Related]
20. Stretching the Limits of Laparoscopy in Gynecological Oncology: Technical Feasibility of doing a Laparoscopic Total Pelvic Exenteration for Palliation in advanced Cervical Cancer.
Puntambekar SP; Agarwal GA; Puntambekar SS; Sathe RM; Patil AM
Int J Biomed Sci; 2009 Mar; 5(1):17-22. PubMed ID: 23675109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
